SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001567619-22-004106
Filing Date
2022-02-14
Accepted
2022-02-14 13:44:11
Documents
2

Document Format Files

Seq Description Document Type Size
1 NONE doc1.htm SC 13G/A 64424
2 EX-99.1 ex99_1.htm EX-99.1 3331
  Complete submission text file 0001567619-22-004106.txt   69387
Mailing Address PARADEPLATZ 8 ZURICH V8 CH 8001
Business Address PARADEPLATZ 8 ZURICH V8 CH 8001 41 44333 2751
CREDIT SUISSE AG/ (Filed by) CIK: 0000824468 (see all company filings)

IRS No.: 135015677
Type: SC 13G/A

Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Subject) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89992 | Film No.: 22629006
SIC: 2834 Pharmaceutical Preparations